Primary percutaneous coronary intervention for acute myocardial infarction without on-site cardiac surgery - A single hospital experience in Taitung

Acta Cardiologica Sinica

Volumn 23, Issue 3, 2007, Pages 160-168

  Cheng, Hsiao Yang ^a   Yeh, Hung I ^a   Hou, Charies Jai Yin ^a   Tsai, Cheng Ho ^a   Wang, Kuangte ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acute myocardial infarction; On site cardiac surgery; Primary percutaneous coronary intervention

Indexed keywords

ALTEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY STENT; ELECTROCARDIOGRAM; EMERGENCY SURGERY; EXPERIENCE; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HOSPITAL; HOSPITAL ADMISSION; HUMAN; IN-STENT RESTENOSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; RIGHT CORONARY ARTERY; SEPSIS; ST SEGMENT ELEVATION; SURVIVAL RATE; TAIWAN;

EID: 36549017282     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction: The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med 1997;336:1621-8.
2. Gibson CM. NRMI and current treatment patterns for ST-elevation myocardial infarction. Am Heart J 2004;148:S29-33.
3. Zahn R, Schiele R, Schneider S, et al. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis: results from the pooled data of Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). J Am Coll Cardiol 2000;36:2064-71.
4. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "Real World": One-Year Results From a Nationwide French Survey. Circulation 1999;99:2639-44.
5. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8.
6. Keeley EC, Boura JA, Grines CL, et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003;361:13-20.
7. Zijlstra F, Hoorntje CA J, Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341:1413-9.
8. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
9. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: for Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993;328:673-9.
10. Wharton TP. Should patients with acute myocardial infarction be transferred to a tertiary center for primary angioplasty or receive it at qualified hospitals in the community? The case for community hospital angioplasty. Circulation 2005;112:3509-34.
11. ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction-Executive Summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 2004;44:671-719.
12. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:216-35.
13. Wang KT, Chen CY, Hou C JY, et al. Comparison of clinical characteristics of acute myocardial infarction (AMI) in aborigines and non-aborigines in Taitung area of Taiwan. Angiology.
14. Vermeer F, Ophuis AJ, Berg EJ, et al. Prospective randomized comparison between thrombolysis, rescue PTCA and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 1999;82:426-31.
15. Grimes CL, Westerhausen DR, Grines LL, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. The Air Primary Angioplasty in Myocardial Infarction Study. J Am Coll Cardiol 2002;39:1713-9.
16. Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory: The PRAGUE Study. Eur Heart J 2000;21:823-31.
17. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial - PRAGUE-2. Eur Heart J 2003;24:94-104.
18. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction, for the DANAMI-2 investigators. N Engl J Med 2003;349:733-42.
19. Nallamothu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States, National Registry of Myocardial Infarction (NRMI)-3/4 Analysis. Circulation 2005;111:761-7.
20. Dalby M, Bouzamondo A, Lechat P, et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infraction: a meta-analysis. Circulation 2003;108:1809-14
21. Keeley EC, Grimes CL. Should patients with acute myocardial infraction be transferred to a tertiary center for primary angioplasty or receive it at qualified hospitals in the community? The case for emergency transfer for primary percutaneous coronary intervention. Circulation 2005;112:3520-32;discussion 3533.
22. Singh M, Ting HH, Berger PB, et al. Rationale for on-site cardiac surgery for primary angioplasty: a time for reappraisal. J Am Coll Cardiol 2002;39:1881-9.
23. Yang EH, Gumina RJ, Lennon RJ, et al. Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003. J Am Coll Cardiol 2005;46:2004-9.
24. Haan CK, O'Brien S, Edwards FH, et al. Trends in emergency coronary artery bypass grafting after percutaneous coronary intervention, 1994-2003. Ann Thorac Surg 2006;81:1658-65.
25. Singh M. Primary angioplasty should be performed in hospitals without on-site surgery. Catheter Cardiovasc Interv 2005;65:1-7.
26. Nallamouthu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States. National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005;111:761-7.
27. McNamara NS, Wharton TP, Rochelle TL, et al. Use of intraaortic balloon counterpulsation in patients with acute myocardial infarction who present to community hospitals. Crit Path in Cardiol 2002;1:159-79.
28. Lavi S, Gruberg L, Kapeliovich M, et al. The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients. J Invasive Cardiol 2005;17:296-9.
29. Luca GD, Suryapranata H, Stone GW, et al. Relationship between patient's risk profile and benefits in mortality from adjunctive Abcixmab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. J Am Coll Cardiol 2006;47:683-91.
30. Luca GD, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005;293:1759-65.
31. Berger JS, Friedman V, Brown DL. Comparison of outcomes in acute myocardial infarction treated with coronary angioplasty alone versus coronary stent implantation. Am J Cardiol 2006;97:977-80.
32. Klein LW, Shaw RE, Krone RJ, et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model, for the American College of Cardiology National Cardiovascular Data Registry. Am J Cardiol 2005;96:35-41.
33. Carruthers KF, Dabbous OH, Flather MD, et al. Contemporay management of acute coronary syndromes: Does the practice match the evidence? The Global Registry of Acute Coronary Events (GRACE). Heart 2005;91:290-8.
34. Politi A, Galli M, Zerboni S, et al. Operator volume and outcomes of primary angioplasty for acute myocardial infarction in a single high-volume center. J Cardiovasc Med 2006;7:761-7.
35. Wharton TP. Increasing the speed and delivery of primary percutaneous coronary intervention in the community. Should the ACC/AHA Guidelines be revisited? Crit Path in Cardiol 2006;5:34-43.